M. Foretz and B. Viollet, Les nouvelles promesses de la metformine, m??decine/sciences, vol.26, issue.1, pp.82-92, 2014.
DOI : 10.1051/medsci/201026121056

URL : http://www.medecinesciences.org/articles/medsci/pdf/2014/01/medsci20143001p82.pdf

C. Bailey, R. Turner, and . Metformin, Metformin, New England Journal of Medicine, vol.334, issue.9, pp.574-583, 1996.
DOI : 10.1056/NEJM199602293340906

P. Pentikäinen, P. Neuvonen, and A. Penttilä, Pharmacokinetics of metformin after intravenous and oral administration to man, European Journal of Clinical Pharmacology, vol.16, issue.Suppl. 1, pp.195-202, 1979.
DOI : 10.1007/BF00562061

G. Graham, J. Punt, M. Arora, R. Day, M. Doogue et al., Clinical Pharmacokinetics of Metformin, Clinical Pharmacokinetics, vol.11, issue.4, pp.81-98, 2011.
DOI : 10.1111/j.1464-5491.1994.tb00253.x

A. Scheen, Clinical Pharmacokinetics of Metformin, Clinical Pharmacokinetics, vol.30, issue.5, pp.359-71, 1996.
DOI : 10.2165/00003088-199630050-00003

C. Wilcock and C. Bailey, Accumulation of metformin by tissues of the normal and diabetic mouse, Xenobiotica, vol.37, issue.1, pp.49-57, 1994.
DOI : 10.1016/S0168-8227(88)80022-6

J. Jonker, E. Wagenaar, C. Mol, M. Buitelaar, H. Koepsell et al., Reduced Hepatic Uptake and Intestinal Excretion of Organic Cations in Mice with a Targeted Disruption of the Organic Cation Transporter 1 (Oct1 [Slc22a1]) Gene, Molecular and Cellular Biology, vol.21, issue.16, pp.5471-5478, 2001.
DOI : 10.1128/MCB.21.16.5471-5477.2001

Y. Shu, S. Sheardown, C. Brown, R. Owen, S. Zhang et al., Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action, Journal of Clinical Investigation, vol.117, issue.5, pp.1422-1453, 2007.
DOI : 10.1172/JCI30558DS1

E. Chen, X. Liang, S. Yee, E. Geier, S. Stocker et al., Targeted Disruption of Organic Cation Transporter 3 Attenuates the Pharmacologic Response to Metformin, Molecular Pharmacology, vol.88, issue.1, pp.75-83, 2015.
DOI : 10.1124/mol.114.096776

M. El-mir, V. Nogueira, E. Fontaine, N. Avéret, M. Rigoulet et al., Dimethylbiguanide Inhibits Cell Respiration via an Indirect Effect Targeted on the Respiratory Chain Complex I, Journal of Biological Chemistry, vol.1364, issue.2, pp.223-231, 2000.
DOI : 10.1002/(SICI)1099-1263(199711/12)17:6<409::AID-JAT462>3.0.CO;2-B

URL : https://hal.archives-ouvertes.fr/inserm-00390049

D. Argaud, H. Roth, N. Wiernsperger, and X. Leverve, Metformin decreases gluconeogenesis by enhancing the pyruvate kinase flux in isolated rat hepatocytes, European Journal of Biochemistry, vol.119, issue.3, pp.1341-1349, 1993.
DOI : 10.1042/bj1190501

URL : https://hal.archives-ouvertes.fr/inserm-00390262

M. Yin, I. Van-der-horst, J. Van-melle, C. Qian, W. Van-gilst et al., Metformin improves cardiac function in a nondiabetic rat model of post-MI heart failure, AJP: Heart and Circulatory Physiology, vol.301, issue.2, pp.459-468, 2011.
DOI : 10.1152/ajpheart.00054.2011

S. Gundewar, J. Calvert, S. Jha, I. Toedt-pingel, S. Ji et al., Activation of AMP-Activated Protein Kinase by Metformin Improves Left Ventricular Function and Survival in Heart Failure, Circulation Research, vol.104, issue.3, pp.403-414, 2009.
DOI : 10.1161/CIRCRESAHA.108.190918

J. Evans, L. Donnelly, A. Emslie-smith, D. Alessi, and A. Morris, Metformin and reduced risk of cancer in diabetic patients, BMJ, vol.330, issue.7503, pp.1304-1309, 2005.
DOI : 10.1136/bmj.38415.708634.F7

X. Huang, S. Wullschleger, N. Shpiro, V. Mcguire, K. Sakamoto et al., Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTENdeficient mice, Biochem J. 1 juin, vol.412, issue.2, pp.211-232, 2008.

E. Beck and A. Scheen, Quels b??n??fices antitumoraux attendre de la metformine???, Annales d'Endocrinologie, vol.74, issue.2, pp.137-184, 2013.
DOI : 10.1016/j.ando.2013.02.009

A. Protti, F. Fortunato, M. Monti, S. Vecchio, S. Gatti et al., Metformin overdose, but not lactic acidosis per se, inhibits oxygen consumption in pigs, Critical Care, vol.16, issue.3, p.75, 2012.
DOI : 10.1186/cc11332

URL : http://doi.org/10.1186/cc11332

S. Piel, J. Ehinger, E. Elmér, and M. Hansson, Metformin induces lactate production in peripheral blood mononuclear cells and platelets through specific mitochondrial complex I inhibition, Acta Physiologica, vol.286, issue.Pt 3, pp.171-80, 2015.
DOI : 10.1074/jbc.M110.208447

R. Defronzo and A. Goodman, Efficacy of Metformin in Patients with Non-Insulin-Dependent Diabetes Mellitus, New England Journal of Medicine, vol.333, issue.9, pp.541-550, 1995.
DOI : 10.1056/NEJM199508313330902

I. Campbell and H. Howlett, Worldwide Experience of Metformin as an Effective Glucose-lowering Agent: A Meta-analysis, Diabetes/Metabolism Reviews, vol.4, issue.S1, pp.57-62, 1995.
DOI : 10.1016/0306-3623(93)90411-P

R. Rachmani, I. Slavachevski, Z. Levi, B. Zadok, Y. Kedar et al., Metformin in patients with type 2 diabetes mellitus: reconsideration of traditional contraindications, European Journal of Internal Medicine, vol.13, issue.7, p.428, 2002.
DOI : 10.1016/S0953-6205(02)00131-0

R. Defronzo, Pharmacologic Therapy for Type 2 Diabetes Mellitus, Annals of Internal Medicine, vol.131, issue.4, pp.281-303, 1999.
DOI : 10.7326/0003-4819-131-4-199908170-00008

M. Stang, D. Wysowski, and D. Butler-jones, Incidence of lactic acidosis in metformin users, Diabetes Care, vol.22, issue.6, pp.925-932, 1999.
DOI : 10.2337/diacare.22.6.925

R. Misbin, L. Green, B. Stadel, J. Gueriguian, A. Gubbi et al., Lactic Acidosis in Patients with Diabetes Treated with Metformin, New England Journal of Medicine, vol.338, issue.4, pp.265-271, 1998.
DOI : 10.1056/NEJM199801223380415

B. Wiholm and M. Myrhed, Metformin-associated lactic acidosis in Sweden, 1977.

I. Van-berlo-van-de-laar, C. Vermeij, and C. Doorenbos, Metformin associated lactic acidosis: incidence and clinical correlation with metformin serum concentration measurements, Journal of Clinical Pharmacy and Therapeutics, vol.5, issue.3, pp.376-82, 2011.
DOI : 10.1046/j.1463-1326.2003.00241.x

J. Duong, T. Furlong, D. Roberts, G. Graham, J. Greenfield et al., The Role of Metformin in Metformin-Associated Lactic Acidosis (MALA): Case Series and Formulation of a Model of Pathogenesis, Drug Safety, vol.180, issue.4, 2013.
DOI : 10.1016/j.toxlet.2008.06.793

J. Lalau and J. Race, Lactic acidosis in metformin therapy: searching for a link with metformin in reports of ???metformin-associated lactic acidosis???, Diabetes, Obesity and Metabolism, vol.4, issue.Suppl., pp.195-201, 2001.
DOI : 10.2337/diacare.20.2.232b

K. Cusi, A. Consoli, and R. Defronzo, Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus, J Clin Endocrinol Metab. nov, vol.81, issue.11, pp.4059-67, 1996.

S. Salpeter, E. Greyber, G. Pasternak, and E. Salpeter, Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. The Cochrane Library, 2010.

A. Jebawi, M. Lassman, and N. Abourizk, Lactic Acidosis With Therapeutic Metformin Blood Level in a Low-Risk Diabetic Patient, Diabetes Care, vol.21, issue.8, pp.1364-1369, 1998.
DOI : 10.2337/diacare.21.8.1364

J. Lalau, C. Lacroix, P. Compagnon, B. De-cagny, J. Rigaud et al., Role of Metformin Accumulation in Metformin-Associated Lactic Acidosis, Diabetes Care, vol.18, issue.6, pp.779-84, 1995.
DOI : 10.2337/diacare.18.6.779

J. Lalau and J. Race, Metformin and lactic acidosis in diabetic humans, Diabetes, Obesity and Metabolism, vol.21, issue.3, pp.131-138, 2000.
DOI : 10.1042/cs0640573

M. Owen, E. Doran, and A. Halestrap, Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain, Biochem J. 15 juin, vol.348, issue.3, pp.607-621, 2000.

B. Brunmair, K. Staniek, F. Gras, N. Scharf, A. Althaym et al., Thiazolidinediones, Like Metformin, Inhibit Respiratory Complex I: A Common Mechanism Contributing to Their Antidiabetic Actions?, Diabetes, vol.53, issue.4, pp.1052-1061, 2004.
DOI : 10.2337/diabetes.53.4.1052

URL : http://diabetes.diabetesjournals.org/content/diabetes/53/4/1052.full.pdf

J. Lalau, J. Race, and L. Brinquin, Lactic Acidosis in Metformin Therapy: Relationship between plasma metformin concentration and renal function, Diabetes Care, vol.21, issue.8, pp.1366-1373, 1998.
DOI : 10.2337/diacare.21.8.1366

K. Kopec and M. Kowalski, Metformin-Associated Lactic Acidosis (MALA): Case Files of the Einstein Medical Center Medical Toxicology Fellowship, Journal of Medical Toxicology, vol.23, issue.1, pp.61-67, 2013.
DOI : 10.2337/diacare.19.12.1449

J. Orban, A. Ghaddab, O. Chatti, and C. Ichai, [Metformin-associated lactic acidosis]. Ann Fr Anesthèsie Rèanimation, oct, vol.25, issue.10, pp.1046-52, 2006.

A. Seidowsky, S. Nseir, N. Houdret, and F. Fourrier, Metformin-associated lactic acidosis: A prognostic and therapeutic study*: Crit Care Med, juill, vol.37, issue.7, pp.2191-2197, 2009.
DOI : 10.1097/ccm.0b013e3181a02490

C. Yeung, H. Chung, B. Fong, N. Tsai, W. Chan et al., Metformin-Associated Lactic Acidosis in Chinese Patients with Type II Diabetes, Pharmacology, vol.40, issue.5-6, pp.260-265, 2011.
DOI : 10.1081/CLT-120004407

N. Peters, N. Jay, D. Barraud, A. Cravoisy, L. Nace et al., Metformin-associated lactic acidosis in an intensive care unit, Critical Care, vol.12, issue.6, p.149, 2008.
DOI : 10.1186/cc7137

URL : https://ccforum.biomedcentral.com/track/pdf/10.1186/cc7137?site=ccforum.biomedcentral.com

C. Lacroix, P. Danger, and F. Wojciechowski, Microassay of plasma and erythrocyte metformin by high performance liquid chromatography], Ann Biol Clin, vol.49, issue.2, pp.98-101, 1991.

J. Lalau and C. Lacroix, Measurement of metformin concentration in erythrocytes:clinical implications, Diabetes, Obesity and Metabolism, vol.20, issue.2, pp.93-101, 2003.
DOI : 10.1046/j.1463-1326.2000.00053.x

G. Tucker, C. Casey, P. Phillips, H. Connor, J. Ward et al., Metformin kinetics in healthy subjects and in patients with diabetes mellitus., British Journal of Clinical Pharmacology, vol.10, issue.2, pp.235-281, 1981.
DOI : 10.1002/jps.2600670524

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1401849/pdf

F. Robert, S. Fendri, L. Hary, C. Lacroix, M. Andréjak et al., Kinetics of plasma and erythrocyte metformin after acute administration in healthy subjects, Diabetes & Metabolism, vol.29, issue.3, pp.279-83, 2003.
DOI : 10.1016/S1262-3636(07)70037-X

C. Briet, M. Saraval-gross, F. Kajbaf, A. Fournier, L. Hary et al., Erythrocyte metformin levels in patients with type 2 diabetes and varying severity of chronic kidney disease, Clinical Kidney Journal, vol.5, issue.1, pp.65-72, 2012.
DOI : 10.1093/ndtplus/sfr134

F. Kajbaf and J. Lalau, The prognostic value of blood pH and lactate and metformin concentrations in severe metformin-associated lactic acidosis, BMC Pharmacology and Toxicology, vol.37, issue.1, p.22, 2013.
DOI : 10.1097/CCM.0b013e3181a02490

S. Vecchio, A. Giampreti, V. Petrolini, D. Lonati, A. Protti et al., Metformin accumulation: Lactic acidosis and high plasmatic metformin levels in a retrospective case series of 66 patients on chronic therapy, Clinical Toxicology, vol.10, issue.2, pp.129-164, 2014.
DOI : 10.1111/j.1365-2710.2010.01192.x

D. Calello, K. Liu, T. Wiegand, D. Roberts, V. Lavergne et al., Extracorporeal Treatment for Metformin Poisoning, Critical Care Medicine, vol.43, issue.8, pp.1716-1746, 2015.
DOI : 10.1097/CCM.0000000000001002

J. Lalau, P. Westeel, X. Debussche, H. Dkissi, M. Tolani et al., Bicarbonate haemodialysis: an adequate treatment for lactic acidosis in diabetics treated by metformin, Intensive Care Medicine, vol.13, issue.6, pp.383-390, 1987.
DOI : 10.1007/BF00257680

D. Heaney, A. Majid, and B. Junor, Bicarbonate haemodialysis as a treatment of metformin overdose, Nephrology Dialysis Transplantation, vol.12, issue.5, pp.1046-1053, 1997.
DOI : 10.1093/ndt/12.5.1046

P. Guo, L. Storsley, and S. Finkle, Dialysis Rounds???A Dialysis Case Presentation and Discussion???Edited by Roger A. Rodby: Severe Lactic Acidosis Treated with Prolonged Hemodialysis: Recovery After Massive Overdoses of Metformin, Seminars in Dialysis, vol.28, issue.suppl 17, pp.80-83, 2006.
DOI : 10.4158/EP.3.6.359

F. Fourrier and A. Seidowsky, Intoxication par la metformine??: m??canismes de toxicit?? et prise en charge, R??animation, vol.19, issue.6, pp.539-544, 2010.
DOI : 10.1016/j.reaurg.2010.05.011

A. Manini, A. Kumar, D. Olsen, D. Vlahov, and R. Hoffman, Utility of serum lactate to predict drug-overdose fatality, Clinical Toxicology, vol.59, issue.7, pp.730-736, 2010.
DOI : 10.1186/cc7159

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091774/pdf

D. Dell-'aglio, L. Perino, Z. Kazzi, J. Abramson, M. Schwartz et al., Acute Metformin Overdose: Examining Serum pH, Lactate Level, and Metformin Concentrations in Survivors Versus Nonsurvivors: A Systematic Review of the Literature, Annals of Emergency Medicine, vol.54, issue.6, pp.818-841, 2009.
DOI : 10.1016/j.annemergmed.2009.04.023

A. Emslie-smith, D. Boyle, J. Evans, F. Sullivan, A. Morris et al., Contraindications to metformin therapy in patients with Type 2 diabetes-a population-based study of adherence to prescribing guidelines, Diabetic Medicine, vol.7, issue.6, pp.483-491, 2001.
DOI : 10.1136/bmj.315.7107.524

A. Holstein, D. Nahrwold, S. Hinze, and E. Egberts, Contra-indications to metformin therapy are largely disregarded, Diabetic Medicine, vol.21, issue.8, pp.692-698, 1999.
DOI : 10.2337/diacare.21.10.1587

S. Friesecke, P. Abel, M. Roser, S. Felix, and S. Runge, Outcome of severe lactic acidosis associated with metformin accumulation, Critical Care, vol.14, issue.6, p.226, 2010.
DOI : 10.1186/cc9376

URL : https://ccforum.biomedcentral.com/track/pdf/10.1186/cc9376?site=ccforum.biomedcentral.com

K. Mcnamara and G. Isbister, Hyperlactataemia and clinical severity of acute metformin overdose, Internal Medicine Journal, vol.81, issue.4, pp.402-410, 2015.
DOI : 10.1038/sj.clpt.6100193

L. Gall, J. Lemeshow, S. Saulnier, and F. , A New Simplified Acute Physiology Score (SAPS II) Based on a European/North American Multicenter Study, JAMA: The Journal of the American Medical Association, vol.270, issue.24, pp.2957-63, 1993.
DOI : 10.1001/jama.1993.03510240069035

A. Jones, S. Trzeciak, and J. Kline, The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation*, Critical Care Medicine, vol.37, issue.5, pp.1649-54, 2009.
DOI : 10.1097/CCM.0b013e31819def97